No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Tate & Lyle tumbled on Monday as Morgan Stanley downgraded the shares to 'underweight' from 'equalweight' and cut the price target to 500p from 590p.
The bank said there is a higher risk to Tate & Lyle's mid-term targets after Tyson Foods said it would phase out sucralose from US branded products.
MS said there is a risk that more consumer packaged goods companies could follow.
The bank said this could weigh on the share price, with sucralose accounting for around 9% of Tate & Lyle's group sales. It added that investors can find superior investment opportunities elsewhere.
At 1250 BST, the shares were down 6% at 469.53p.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.